Clinical Trial Update: A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial is testing immunotherapy versus capecitabine maintenance after chemo-chemoradiotherapy in high-risk nasopharyngeal cancer; patient enrollment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharangeal Cancer | Phase 2 | Status: RECRUITING